Knee osteoarthrosis secondary to ochronosis -clinical case^☆,^☆☆

Abstracts

Alkaptonuria is a rare metabolic disease in which a deficiency of the enzyme homogentisate dioxygenase causes an accumulation of homogentisic acid. Ochronosis consists of excessive deposition of homogentisic acid in the connective tissue and presents as a chestnut brown or black pigmentation. With aging, the accumulation of pigments from homogentisic acid in the joints causes osteoarthrosis. There is no specific treatment for the disease and the approach is symptomatic. Arthroplasty is the solution for severe cases of osteoarthrosis caused by this pathological condition and presents results comparable to those from patients with primary osteoarthrosis. Here, the case of a 67-year-old patient who underwent several arthroplasty procedures because of osteoarthrosis caused by this rare pathological condition is presented. The last surgical intervention consisted of total right knee arthroplasty.

Alkaptonuria; Ochronosis; Knee; Arthroplasty

A alcaptonúria é uma doença metabólica rara em que a deficiência da enzima ácido homogentísico-oxidase provoca uma acumulação de ácido homogentísico. A ocronose consiste na deposição excessiva de ácido homogentísico no tecido conjuntivo e apresenta-se como uma pigmentação acastanhada ou preta. Com o envelhecimento, a acumulação de pigmentos de ácido homogentísico nas articulações provoca osteoartrose. Não existe um tratamento específico para a doença e a abordagem é sintomática. A artroplastia é a solução para casos graves de osteoartrose causada poressa patologia e apresenta resultados compa-ráveis aos doentes com osteoartrose primária. Os autores apresentam o caso de um doente de 67 anos submetido a várias artroplastias, em virtude da osteoartrose causada por essa rara patologia. A última intervenção cirúrgica foi uma artroplastia total do joelho direito.

Alcaptonúria; Ocronose; Joelho; Artroplastia

Introduction

Alkaptonuria is a rare recessive autosomal metabolic disease caused by absence of the enzyme homogentisic oxidase. This enzyme is responsible for degradation of homogentisic acid, which is an intermediate product from metabolism of the amino acids tyrosine and phenylalanine. If this enzyme is defective, this leads to accumulation of homogentisic acid in tissues and blood.

The incidence of alkaptonuria is less than one in one million.¹

Over time, the deposits of homogentisic acid accumulate in the tissues and present as a dark pigmentation. This condition is called ochronosis and it may affect not only the musculoskeletal system but also the cardiovascular and genitourinary systems, the sclera and the skin.²,³

Most of the symptoms of alkaptonuria are only observed starting in the fourth or fifth decade of life,⁴ except for the appearance of dark urine, which is detected during childhood, resulting from excretion and oxidation of homogentisic acid.

Alkaptonuria causes progressive ochronotic arthropathy of the major joints that are subject to weight-bearing. The knee is the joint that is most affected, followed by the hip.⁴–⁶

The treatment for the disease is symptomatic and total arthroplasty is the preferred treatment in severe cases of osteoarthrosis.⁷,⁸

Clinical case

The patient was a 67-year-old man whose diagnosis of alkaptonuria had been made at the age of 40 years. The first signs of the disease were darkening of the urine and appearance of dark pigments in the sclera, ears and first interdigital crease of the left hand (Fig. 1A-D). There were no other relevant antecedents or any family history of the disease.

Fig. 1
Dark pigment in the sclera, ears and first interdigital crease of the left hand. The last figure demonstrates the darkened appearance of the urine.

At the age of 60 years, the patient underwent a surgical intervention to extract a bladder stone of large dimensions (Fig. 2).

Fig. 2
Bladder stone.

Joint complaints arose some years later and initially affected the left hip, followed by the left knee and lastly the right knee.

The patient was referred for an orthopedics consultation and the first surgical intervention was total arthroplasty of the left hip, performed five years before the present case (Fig. 3A and B).

Fig. 3
Cemented total hip arthroplasty performed five years before the present case.

Twelve months before the present case, the patient underwent total arthroplasty of the left knee (Fig. 4A-C). Both of these surgical procedures were performed at another hospital institution. So far, there have not been any mentions of postoperative complications.

Fig. 4
Total arthroplasty of the left knee performed 12 months before the present case. Right knee with three-compartment gonarthrosis of Ahlbäck grade IV.

At the consultation of the present case, the patient presented complaints of pain in his right knee, with a varus knee and radiologically observed three-compartment gonarthrosis of Ahlbäck grade IV (Fig. 4A and B).

The patient underwent total arthroplasty of the right knee (Fig. 5A and B) at our hospital. The complaints of pain improved immediately after the operation.

Fig. 5
Radiograph of the knees with weight-bearing and lateral view of the right knee six months after total arthroplasty.

After six months of follow-up, the patient is now asymptomatic and able to walk without gait supports. His mobility is from 0°to 110° in the right knee and 0°to 120° in the left knee. He continues to be followed up as an outpatient.

Discussion

Alkaptonuria was first described in 1584, in children with dark urine.

At the end of the 1990s, it was observed that the gene for this pathological condition was present at the locus 3q21-23.⁹

Ochronosis consists of deposition of pigments from homogentisic acid in all types of connective tissue and particularly in cartilage. It mainly affects the musculoskeletal system, but can also affect the cardiovascular and genitourinary systems, the sclera and the skin.²,³

The first clinical manifestation of alkaptonuria is the appearance of dark urine.¹⁰ Other alterations that are often neglected include changes to the color of the sclera and ears. These signs could also be identified in our patient.

Ochronotic arthropathy fundamentally affects individuals from the age of 40 years onwards, as seen in the case presented here. The pain complaints affect the major joints and especially the knees, followed by the hips, shoulders, spine and even the ribs.¹¹ In our case, the first joint to be affected was the left hip.

The pigmentation also affects the tendons and ligaments, because of their high collagen content, and it causes inflammatory alterations that may lead to tearing.⁷

Like in patients with primary osteoarthrosis, narrowing of the interline and sclerosis of the joint space are frequently seen. However, the radiological alterations may be much less exuberant than the clinical manifestations.

Macroscopically, patients affected by ochronosis present small particles resembling soot, encrusted in the menisci, tendons and ligaments, which confers the typical dark coloration of the joints. This could be seen in the intraoperative images of the present case (Fig. 6A-C). The anatomopathological examination on the operative specimens confirmed the diagnosis.

Fig. 6
Intraoperative images documenting the typical dark coloration of the joint that resulted from deposition of pigments from homogentisic acid in the joint cartilage, menisci, tendons and ligaments.

There is no specific medical treatment for alkaptonuria and therefore the therapeutic approach is symptomatic. In severe cases of osteoarthrosis, total arthroplasty is the preferred treatment.⁷,⁸

Few studies have reported the mechanical differences that may occur in the bone and soft tissues of patients who undergo arthroplasty, or the complications during the operation or postoperative follow-up.

In patients undergoing total knee arthroplasty, Spencer et al.¹² were faced with intraoperative difficulties in displacing the patella, because the quadriceps and patellar tendons were extremely hard. Although we did not have this difficulty, we observed during the operation that both the hips presented an unusually hard consistency.

In the same study, no complications relating to implant failure were detected in patients with ochronosis who underwent total arthroplasty on different joints, with 12 years of follow-up. Other studies have presented results compatible with performing arthroplasty in patients with primary osteoarthrosis.¹³–¹⁵

Early treatment for alkaptonuria may be a challenge, given that the approach is symptomatic.

Cases of ochronotic arthrosis that are more advanced require surgical treatment.

As already reported total knee arthroplasty presents good results in patients with gonarthrosis secondary to this rare pathological condition.

References

• ¹
  Smith RJ. Disorders of amino acid metabolism. In: Humes HD, editor. Kelley's textbook of internal medicine. 4th ed. Philadelphia: Lippincott Williams 8 Wilkins; 2000. p. 2788-93.
• ²
  Nas K, Gür A, Akdeniz S, Cevik R, Harman M, Saraç AJ. Ochronosis: a case of severe ochronoticarthropathy. Clin Rheumatol. 2002;21(2):170-2.
• ³
  Wauthy P, Seghers V, Mathonet P, Deuvaert FE. Cardiac ochronosis: not so benign. Eur J Cardiothorac Surg. 2009;35(4):732-3.
• ⁴
  Gaines JJ Jr. The pathology of alkaptonuric ochronosis. Hum Pathol. 1989;20(1):40-6.
• ⁵
  Albers SE, Brozena SJ, Glass LF, Fenske NA. Alkaptonuria and ochronosis: case report and review. J Am Acad Dermatol. 1992;27(4):609-14.
• ⁶
  La Du BN Jr. Alcaptonuria and ochronotic arthritis. Mol Biol Med. 1991;8(1):31-8.
• ⁷
  Mannoni A, Selvi E, Lorenzini S, Giorgi M, Airó P, Cammelli D, et al. Alkaptonuria, ochronosis, and ochronoticarthropathy. Semin Arthritis Rheum. 2004;33(4):239–48.
• ⁸
  Borman P, Bodur H, Ciliz D. Ciliz Ochronoticarthropathy. Rheumatol Int. 2002;21(5):205-9.
• ⁹
  Fernández-Canón JM, Granadino B, Beltrán-Valero de Bernabé D, Renedo M, Fernández-Ruiz E, Peñalva MA, et al. The molecular basis of alkaptonuria. Nat Genet. 1996;14(1):19-24.
• ¹⁰
  Resnick D. Alkaptonuria. In: Resnick D, Niwayama G, editors. Diagnosis of bone and joint disorders. 2nd ed. Philadelphia: Saunders; 1988. p. 1787-803.
• ¹¹
  O'Brien W, La Du BN, Bunim JJ. Biochemical, pathologic and clinical aspects of alcaptonuria, ochronosis, and ochronoticarthropathy. Am J Med. 1963;34:813-38.
• ¹²
  Spencer JM, Gibbons CL, Sharp RJ, Carr AJ, Athanasou NA. Arthroplasty for ochronotic arthritis: no failure of 11 replacements in 3 patients followed 6-12 years. Acta Orthop Scand. 2004;75(3):355-8.
• ¹³
  Aydogdu S, Cullu E, Ozsoy MH, Sur H. Cementless total knee arthroplasty in ochronoticarthropathy: a case report with a 4-year follow-up. J Arthroplasty. 2000;15(4):539–43.
• ¹⁴
  Moslavac A, Moslavac S, Cop R. Case report of a patient with ochronosis and arthroplasty of the hip and both knees. Reumatizam. 2003;50(1):26-8.
• ¹⁵
  Carrier DA, Harris CM. Bilateral hip and bilateral knee arthroplasties in a patient with ochronoticarthropathy. Orthop Rev. 1990;19(11):1005-9.

• ☆
  Please cite this article as: da Silva Martins Ferreira AM, Lima Santos F, Castro Costa AM, Pereira Barbosa BM, Reis Rocha RM, Fontes Lebre JF. Osteoartrose do joelho secundária a ocronose - Caso clínico. Rev Bras Ortop. 2014;49:675-680.
• ☆☆
  Work developed in the Vila Nova de Gaia Hospital Center, Vila Nova de Gaia, Portugal, and Espinho Hospital, Espinho, Portugal.

Publication Dates

• Publication in this collection
  Nov-Dec 2014

History

• Received
  05 Oct 2013
• Accepted
  11 Nov 2013